Intestinal microbiota alterations link subclinical inflammation and clinical phenotypes in familial Mediterranean fever
Abstract
IntroductionFamilial Mediterranean fever (FMF) is an autoinflammatory disease caused by mutations in the Mediterranean fever (MEFV) gene. Although FMF is classically associated with serosal inflammation, emerging evidence suggests intestinal involvement. We aimed to investigate subclinical intestinal inflammation in patients with FMF by assessing fecal calprotectin (FCP) levels and intestinal microbial and fecal metabolic profiles.MethodsThirty patients with FMF from three hospitals were stratified into the FCP-high (>94 μg/g) and FCP-low (≤94 μg/g) groups. For intestinal microbiota analysis, patients with FMF were also compared with healthy controls and patients with inflammatory bowel disease unclassified (IBDU) from previous multicenter studies.ResultsElevated FCP levels were detected in 26.7% patients. The FCP-high group had lower hemoglobin levels and a trend toward lower albumin levels. Compared with healthy controls, patients with FMF showed reduced alpha diversity and differences in overall microbiota composition. A higher relative abundance of Bifidobacterium longum and lower relative abundances of Faecalibacterium, Blautia, and Blautia obeum showed exploratory associations with arthritis, as well as lower albumin and hemoglobin levels. The FCP-high group showed greater depletion in the relative abundance of Blautia and nominally higher fecal 2-amino-2-methyl-1-propanol levels. The relative abundance of Lactobacillus, Streptococcus, and Enterococcus showed stepwise increased from healthy controls to the FCP-low FMF, FCP-high FMF, and IBDU with MEFV mutation groups, whereas that of Fusicatenibacter and Agathobacter showed stepwise decreased across these groups.DiscussionThis exploratory study identified associations among FMF, elevated FCP, and alterations in the intestinal microbiota. Elevated FCP in a subset of clinically remitted patients may suggest possible subclinical intestinal inflammatory activity.
Related
- Impaired Fermentation in the Absence of Gut Microbiota Promotes Inulin-Induced Intestinal Inflammation
- Prophage induction contributes to alterations in the gut phageome during intestinal inflammation
- Wdr82-COMPASS coordinates Foxp3 and TCR signaling to sustain Treg cell control of microbiota-driven intestinal inflammation
- Zhuhuang Granules alleviate psoriatic inflammation via restoring gut microbiota balance and enhancing intestinal barrier integrity.
- Dietary prevention of undernutrition reduces intestinal inflammation associated with an anti-inflammatory profile of gut microbiota in a preclinical model
BibTeX
@article{wagatsuma2026intestinal,
title = {{Intestinal microbiota alterations link subclinical inflammation and clinical phenotypes in familial Mediterranean fever}},
author = {Kohei Wagatsuma and Tomohiro Koga and Kiyoshi Migita and Shoichi Fukui and Yushiro Endo and Kenji Saito and Haruki Matsumoto and Shu Tamano and Masanori Nojima and Masashi Idogawa and Motohiro Esaki and Taku Kobayashi and Fumihito Hirai and Katsuhiro Arai and Ryuta Nishikomori and Atsushi Kawakami and Tadakazu Hisamatsu and Hiroshi Nakase},
journal = {Frontiers in Immunology},
year = {2026},
month = nov,
doi = {10.3389/fimmu.2026.1956259},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1956259},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Intestinal microbiota alterations link subclinical inflammation and clinical phenotypes in familial Mediterranean fever
AU - Kohei Wagatsuma
AU - Tomohiro Koga
AU - Kiyoshi Migita
AU - Shoichi Fukui
AU - Yushiro Endo
AU - Kenji Saito
AU - Haruki Matsumoto
AU - Shu Tamano
AU - Masanori Nojima
AU - Masashi Idogawa
AU - Motohiro Esaki
AU - Taku Kobayashi
AU - Fumihito Hirai
AU - Katsuhiro Arai
AU - Ryuta Nishikomori
AU - Atsushi Kawakami
AU - Tadakazu Hisamatsu
AU - Hiroshi Nakase
PY - 2026
DA - 2026/11/10
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1956259
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1956259
AB - IntroductionFamilial Mediterranean fever (FMF) is an autoinflammatory disease caused by mutations in the Mediterranean fever (MEFV) gene. Although FMF is classically associated with serosal inflammation, emerging evidence suggests intestinal involvement. We aimed to investigate subclinical intestinal inflammation in patients with FMF by assessing fecal calprotectin (FCP) levels and intestinal microbial and fecal metabolic profiles.MethodsThirty patients with FMF from three hospitals were stratified into the FCP-high (>94 μg/g) and FCP-low (≤94 μg/g) groups. For intestinal microbiota analysis, patients with FMF were also compared with healthy controls and patients with inflammatory bowel disease unclassified (IBDU) from previous multicenter studies.ResultsElevated FCP levels were detected in 26.7% patients. The FCP-high group had lower hemoglobin levels and a trend toward lower albumin levels. Compared with healthy controls, patients with FMF showed reduced alpha diversity and differences in overall microbiota composition. A higher relative abundance of Bifidobacterium longum and lower relative abundances of Faecalibacterium, Blautia, and Blautia obeum showed exploratory associations with arthritis, as well as lower albumin and hemoglobin levels. The FCP-high group showed greater depletion in the relative abundance of Blautia and nominally higher fecal 2-amino-2-methyl-1-propanol levels. The relative abundance of Lactobacillus, Streptococcus, and Enterococcus showed stepwise increased from healthy controls to the FCP-low FMF, FCP-high FMF, and IBDU with MEFV mutation groups, whereas that of Fusicatenibacter and Agathobacter showed stepwise decreased across these groups.DiscussionThis exploratory study identified associations among FMF, elevated FCP, and alterations in the intestinal microbiota. Elevated FCP in a subset of clinically remitted patients may suggest possible subclinical intestinal inflammatory activity.
SN - 1664-3224
ER -